Our analysis of 63,992 individuals identified a complete freedom from headache (CFH) risk locus in ADARB2. We replicate the genomic risk locus in a non-overlapping cohort, although the lead SNP did not reach statistical significance. Here, ADARB2 is linked to Headache.